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Abstract 
Stress can cause or contribute to bladder dysfunction though specific effects 
remain unclear. Individuals with interstitial cystitis (IC)/bladder pain syndrome 
(BPS) experience increased symptom severity with stress, including pain and 
increased urgency and frequency of voiding. Further research can identify stress-
related changes to urinary mechanisms, such as changes in sensory 
neurotransmitters and subsequent receptor expression.  These factors could then 
become targets for future therapies providing bladder dysfunction relief. Alterations 
in PACAP and TRPV channel expression have been shown in sensory pathways in 
response to disease. My research studied the effects of chronic stress on bladder 
function and the potential for PACAP(6-38), a PACAP antagonist, to recover normal 
function. Mice went through a repeated variate stress regime followed by bladder 
tube implant and cystometrogram recording. Bladder, dorsal root ganglia (DRG), 
and spinal cord tissues were collected and immunostained for the presence of 
TRPV1, TRPV4, and PACAP expression. Chronic stress decreased inter-contraction 
interval (ICI) and bladder capacity while increasing bladder pressures. Both control 
and stressed male and female mice showed improvement following a 30-minute 
intravesical infusion of PACAP(6-38), with ICI and bladder capacity measures 
having the most consistent improvement across groups. PACAP and TRPV1 
expression was upregulated in the bladder afferent pathway. These findings suggest 
that chronic stress can contribute to bladder dysfunction, and it seems to be 
mediated in part by upregulation of PACAP and TRPV channel activity. With further 
research, these factors may be valid molecular targets for therapy. As chronic stress 
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may present alone or in combination with other conditions (IC/BPS, injury, etc.), it 
is critical to understand stress-related changes in order to reduce or eliminate their 
impact.  
Introduction 
Normal bladder function is usually unappreciated until something goes 
wrong. An estimated 3.3 to 7.8 million adult females in the U.S. alone suffer 
symptoms of IC/BPS (Berry et al., 2011). IC/BPS is a debilitating inflammatory 
disease that impedes daily activities and makes participating in the community 
difficult through persistent discomfort and bladder dysfunction (Beckett et al., 
2014). Chronic stress, related or unrelated to the disease, may exacerbate symptoms 
and thus reduce quality of life further (Robbins et al., 2007; Rothrock et al., 2001). 
Additionally, chronic stress, as an inflammatory condition, may be able to 
independently cause bladder dysfunction with a presentation similar to IC/BPS 
(Smith et al., 2011). Currently, the mechanisms by which stress contributes to 
bladder dysfunction are unknown, and there is no cure besides removing the 
stressor(s), which is not always possible. Also, there is no cure for IC/BPS. This 
research is intended to make progress towards these goals. 
The Basics of Bladder Innervation  
The bladder is composed of four layers – an inner endothelial layer of 
epithelium, the lamina propria (connective tissue and vasculature), the detrusor 
smooth muscle, and the perivesical soft tissue (fat and vasculature). The inferior 
aspect of the bladder is the bladder neck, containing the more superior internal 
sphincter (smooth muscle) and the external urethral sphincter (striated muscle). 
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These components all work together to achieve two modes of operation:  storage 
and elimination.  
Normal urinary bladder function is a consistent, repetitive cycle of storage 
and voiding (micturition) controlled by conscious and autonomic inputs (de Groat et 
al., 1993). In a mature urinary system, bladder filling occurs with somatic and 
sympathetic contraction of the sphincter muscles and sympathetic inhibition of 
detrusor smooth muscle activity (de Groat & Booth, 1980). Sensory nerves relay 
information about fullness from the bladder to the spinal cord, where there are 
localized reflex pathways that also project to the pontine micturition center and 
cerebral cortex (Mahony et al., 1977; Zhang et al., 2005). Parasympathetic 
innervation contracts the detrusor muscle whereas sympathetic and somatic 
innervation relaxes the sphincter muscles, which together allows for voiding 
(Edvardsen, 1972; Mahony et al., 1977).  
Changes in these pathways produce voiding dysfunctions because neural 
control as well as detrusor muscle activity is often altered. This presents as changes 
(often increases) in voiding frequency, nocturia, urgency, incomplete emptying, 
urinary hesitancy, and suprapubic pain (Irwin et al., 2006; Koziol et al., 1993). These 
changes are studied functionally by measuring bladder capacity, ICI (the time 
between voids), and pressure values throughout a micturition cycle (Maggi et al., 
1986; Schafer et al., 2002). Pressures are lowest right after voiding when the 
bladder is empty. Pressure remains steady throughout the filling phase until it 
dramatically increases just prior to voiding (Maggi et al., 1986). Unstable or 
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consistently elevated pressures throughout a micturition cycle suggest dysfunction 
(Malmgren, 1987; Neal et al., 1987).  
States of urinary bladder dysfunction are usually caused by changes to 
autonomic control of the system (as opposed to conscious inputs). This can happen 
through changes in perceived bladder sensations, which occurs when expression of 
sensory molecules and their channels are altered in the bladder afferent relay. For 
example, two channels in the transient receptor potential (TRP) superfamily, 
transient receptor potential vanilloid family member 1 (TRPV1) and member 4 
(TRPV4), are important in maintaining proper bladder sensation and activity, and 
have increased expression levels in IC/BPS (Everaerts et al., 2010; Wang et al., 
2008). As such, studying these channels in their relation to bladder dysfunction has 
lead to a better understanding of IC/BPS physiology and potential treatments. 
Relative location and density of these channels indicate specific functional 
contributions in supporting normal voiding behavior (Yamada et al., 2009).  
TRPV1 
TRPV1 channels are temperature-sensitive and respond to a variety of 
sensory molecules that will transmit nociception, including nerve growth factor 
(NGF), bradykinin, and capsaicin (Chuang et al., 2001). These channels are 
expressed in afferent nerves that relay information on bladder distension and 
chemical irritation from the urinary bladder (Yamada et al., 2009). Activation of 
these channels causes perceived pain, bladder hypersensitivity, and compromised 
bladder function. Birder and colleagues (2001) found TRPV1 channels in the 
urothelium cells as well. TRPV1(-/-) mice have more non-voiding bladder 
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contractions than control mice and a loss of unconscious reflexive voiding (Birder et 
al., 2002). This suggests a role for TRPV1 in normal bladder function, as there is 
dysfunction present without it. Desensitizing TRPV1 channels using capsaicin did 
not impact ICI in these mice, though it did have a negative effect on ICI in controls 
(Birder et al., 2002). These results suggest that the TRPV1 is important in detecting 
irritants like capsaicin and amplifying the signal as it travels towards spinal and 
brain centers to evoke a response. This indicates that TRPV1 acts in a 
physiologically relevant manner in bladder afferents.  
TRPV4 
Previous studies have indicated that TRPV4 channels may function as a 
sensor of mechanical pressure in the bladder. Extensive TRPV4 expression has been 
found in the urothelium (Yamada et al., 2009). Alessandri-Haber and colleagues 
(2003) demonstrated that TRPV4 acts on primary afferent nerve fibers in response 
to changes in osmolarity and/or mechanical stretch. It seems that these fibers are 
mechanosensitive but capsaicin-insensitive nociceptive (pain) fibers (Aizawa et al., 
2011). Activation of TRPV4 caused pain-related behavior in rats, supporting the idea 
that the channel is involved in sensory transmission (Alessandri-Haber et al., 2003). 
These behaviors were not seen in TRPV4 knockout mouse models (Alessandri-
Haber et al., 2003). This suggests that TRPV4 signaling is required for hypotonic-
related nociception. Guler and colleagues (2002) also found that TRPV4 channels 
are activated in response to warm temperatures, with increased sensitivity to heat 
responses in hypo-osmotic solutions. This suggests that TRPV4 could be a 
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multimodal receptor, responding to and integrating at least two types of sensory 
information.  
The functional significance of TRPV4 has not been fully elucidated, but clear 
behavior changes have been found. Mice without TRPV4 channels in the urinary 
bladder have fewer voiding contractions (Gevaert et al., 2007). Similarly, research 
by Everaerts and colleagues (2010) has also shown difficulty in producing high 
cystitis-like voiding frequencies in mice TRPV4 (-/-) mice. Merrill and colleagues 
(2012) found increased expression levels of TRPV4 in chronic cystitis. Similar 
bladder function changes have been seen with stress models. Merrill & Vizzard 
(2014) found increased TRPV4 expression in the urinary bladder following stress. 
Similar results occurred in control mice with TRPV4 agonist administration, 
suggesting that increased TRPV4 expression may contribute to bladder dysfunction 
(Merrill & Vizzard, 2014).  These decreases in bladder capacity with increases in 
TRPV4 expression suggest that this channel has an important mechanosensor role 
in normal bladder function.  
In control and cystitis-model mice, TRPV4 antagonist action increases 
bladder capacity and reduces ICI (Thorneloe et al., 2008). There was also an 
improvement in bladder capacity and ICI following TRPV4 antagonist 
administration in stressed animal models (Merrill & Vizzard, 2014). By detecting 
changes in bladder wall stretch, these receptors signal apparent bladder fullness.  
These results suggest the involvement of TRPV4 in normal bladder function, as well 
as a possible role in the response to stress and cystitis. 
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Pituitary adenylate cyclase-activating polypeptide (PACAP) 
PACAP-38, first isolated by Miyata and colleagues (1989), is a well-conserved 
sensory neurotransmitter in mammals with a widespread presence throughout the 
central and peripheral nervous systems. Dun and colleagues (1996) found PACAP-
immunoreactivity (PACAP-IR) in the dorsal horn of the spinal cord, with light 
expression in ventral horn. A distribution primarily in the dorsal horn suggests 
involvement in sensory and autonomic activity. With administration of capsaicin, 
the number and intensity of PACAP-IR nerve fibers were reduced in the lower 
urinary tract (LUT; comprised of the bladder, urethra, and prostate) (Fahrenkrug & 
Hannibal, 1998). This led them to propose that PACAP expression depends on 
sensory input. Helyes and colleagues (2007) went on to show that PACAP is released 
by capsaicin-sensitive neurons into systemic circulation. This would support the 
idea that PACAP does respond to sensory information, as we know that capsaicin-
responsive neurons are located in the afferent limb of bladder innervation. This also 
suggests co-localization of PACAP with TRPV1 channels in urinary bladder afferents.  
Variations in PACAP levels have been shown to cause a variety of functional 
changes in the micturition process. PACAP-38 was found to produce relaxation of 
the pig urinary bladder neck through PACAP receptor activation and subsequent 
inhibitory signaling (Hernandez et al., 2006). The bladder neck is the sphincter 
smooth muscle that, when relaxed, allows for voiding. High levels of PACAP may 
then prompt repeated relaxations of this muscle that may contribute to high levels 
of non-voiding contractions of the detrusor. This effect was diminished with 
administration of the antagonist PACAP(6-38) (Hernandez et al., 2006). PACAP (-/-) 
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mice show increased bladder capacity, ICI, and void volume (May & Vizzard, 2010). 
The detrusor was contracted for significantly longer than controls and there was a 
large residual volume (May & Vizzard, 2010). PACAP has been observed in spinal 
cord (L1, L2, and L4-S1) and DRG (L1, L2, L6, and S1), with an increase in expression 
after chronic cystitis (Vizzard, 2000). This shows further presence in afferent 
signaling.  
Girard and colleagues (2013) demonstrated an increase in TRPV4 expression 
in the lumbosacral (L1, L2, L6-S1) DRGs in transgenic mice with a chronic 
overexpression of nerve growth factor (NGF), which regulates PACAP and its 
receptors. Mice with chronic overexpression of NGF at the level of the urinary 
bladder exhibit significantly increased voiding frequency. This suggests that TRPV4 
channel changes may show similarities to changes in PACAP, which aids in detrusor 
muscle contraction for voiding. Combined with the understanding that TRPV1 and 
PACAP are expressed in capsaicin-sensitive neurons, these factors seem to be co-
expressed.  
An increase in PACAP expression with cystitis could explain bladder 
overactivity. The blockade of PACAP-selective channels using the antagonist 
PACAP(6-38) reduces urinary frequency in rats with bladder inflammation induced 
by cyclophosphamide (CYP) (Braas et al., 2005). This is supported by research 
demonstrating a decrease in bladder overactivity with PACAP(6-38) administration 
in rodent models of chronic spinal cord injuries, another inflammatory condition 
(Yoshiyama & de Groat, 2008). Because stress can lead to inflammation and 
previous cystitis models shown upregulation in PACAP and TRPV channels (Braas et 
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al., 2005; Girard et al., 2013; Vizzard, 2000), the expression of both PACAP and TRPV 
channels after prolonged stress is expected to be similar to that seen with cystitis. 
Previous research has also suggested that PACAP and TRPV channels are both 
expressed in small diameter DRG neurons (Helliwell et al., 1998; Moller et al., 1993). 
Because of similar function and co-expression, alleviation of stress-related urinary 
symptoms may be possible through alterations of these mechanisms. This may 
provide insight into possible targets for drugs to help provide relief for voiding 
changes seen in inflammatory conditions.  
Bladder Function & Stress 
Bladder dysfunction reduces quality of life through psychosocial factors, 
including financial, social, physical, and emotional stress. Severe symptoms can limit 
patients’ confidence to travel far from their homes. IC/BPS has been shown to lead 
to increased likelihood of missing or quitting work through collective symptom 
impact, depressive symptoms, and co-morbidities (Beckett et al., 2014). These 
comorbidities may often be mental health concerns. For example, there is an 
increased prevalence of IC/BPS in those diagnosed with anxiety disorders (Clemens, 
Brown, & Calhoun, 2008). Life stressors can exacerbate bladder dysfunction. 
Rothrock and colleagues (2001) have found that higher levels of stress are related to 
increased IC/BPS symptoms.  
Although many functional changes in LUT physiology have been implicated 
in IC/BPS, stress-related changes to urinary sensory mechanisms are largely 
unknown. These physiological changes, however, are very important to understand 
and create therapies for stress-related bladder dysfunction. This research will 
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include studying changes in the relay of the message via modulation of ion channel 
and neuropeptide expression at key locations (e.g., urinary bladder, spinal cord, and 
DRG) in the voiding reflex, and advancing this knowledge may eventually contribute 
toward providing relief to millions with bladder dysfunction. Following chronic 
stress, I hypothesize that there is increased expression and co-expression of TRPV1 
and TRPV4 channels with PACAP in the lumbosacral (L1, L2, L6, and S1) DRG.  I also 
hypothesize that chronic stress will increase voiding frequency and threshold 
pressure, which will be alleviated with PACAP(6-38) administration into the urinary 
bladder. 
Methods 
The work was completed in the Vizzard Laboratory in the Given Building and 
in the Given Animal Care Facility at the UVM College of Medicine. Dr. Vizzard and 
other laboratory members including a senior research technician and postdoctoral 
associate were available to provide day-to-day guidance and support. All 
experimental protocols involving animals were reviewed and approved by the 
Institutional Animal Care and Use Committee of the University of Vermont. 
Repeated Variate Stress  
PACAP-GFP transgenic mice donated by Dr. James A. Waschek (UCLA) were bred in-
house onto a C57BL/6 background. Adult PACAP-GFP mice (female n=12, male 
n=15) were randomly assigned by cage to control or stressed groups. All animals 
remained housed as they were before the experiment (single or colony), were 
maintained on a 12-hour light/dark cycle, and had access to food and water ad 
libitum. Enrichment was prohibited, including huts. The stressed mice underwent 
 12 
seven days of repeated variate stress, with one stressor per day as seen in Table 1. 
This paradigm works to best resemble life stress, as there are multiple different 
sources of stress that change frequently.  
 
 
Day Stressor Duration 
1 Pedestal 30 minutes 
2 Swim 5 minutes 
3 Foot 
Shock 
two at 5 seconds each, 
separated by one 
minute of rest 
4 Restraint 1 hour 
5 Oscillation 30 minutes 
6 Swim 5 minutes 
7 Foot 
Shock 
two at 5 seconds each, 
separated by one 
minute of rest 
 
Pedestal: Mice were placed on a pedestal platform (7”x7”) three feet from the 
ground for thirty minutes. There was one mouse per platform and the two pedestals 
were placed in the center of black netting to catch any mice that jump or fall off of 
the platform. The platforms were sanitized with an alcohol solution in between mice 
to remove urine and fecal pellets.  
Swim: Mice were forced to swim individually for five minutes in room temperature 
water deep enough that their tails could not touch the bottom of the container. 
Table 1.   The schedule and length of stressor 
events in the chronic variate stress protocol.  
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Afterward, they were placed in a holding cage with super absorbent bedding for five 
minutes before being returned to their home cages.  
Foot Shock: Mice were put in a 30 × 25 × 35 cm (L × W × H) Plexiglas conditioning 
chamber (Med Associates, St. Albans, VT) to acclimate for five minutes. Then, two 
five-second 0.29 mAmp shocks were delivered one minute apart through the 
chamber floor. The drop tray was sanitized in between animals to remove urine and 
fecal pellets. 
Restraint: Mice were placed headfirst into 50mL tubes that were modified such that 
the bottom portion was cut off to provide ventilation and a slit towards the top of 
the tube allowed the tail to rest more naturally outside of the tube. A rubber plug 
with additional ventilation holes was placed into the tubes behind the mouse to 
restrict backward motion. Blocks were placed on either end of the tubes so that they 
could not roll. Mice remained in the tubes for one hour.  
Oscillation: Mice were placed individually into clean and empty standard mouse 
housing cages that were placed on a multi-purpose rotator (Fisher Scientific, Morris 
Plains, NJ) to oscillate for 30 minutes at slow to medium speed.  
Bladder Tube Implant 
After seven days of stress, the mice underwent an intravesical catheter 
implant. Using 2% isoflurane (3% for stressed animals) as general anesthesia, a 
lower midline abdominal incision was made to expose the bladder. Polyethylene 
tubing was inserted into the dome of the bladder and secured using a 6-0 nylon 
purse-string suture. The sealed distal end was tunneled subcutaneously to the back 
of the neck to remain in the subcutaneous space during recovery. The abdominal 
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incision was closed with a chromic gut suture through the abdominal muscle and 
then a 4-0 nylon running stitch externally. The neck incision was closed with 4-0 
nylon stitch and both incision sites were covered with GLUture. Buprenorphine 
(0.03 μl dose of .05 mg/ml) and carprofen (0.01 ml/g dose of 0.05 mg/ml) 
administered subcutaneously were given as analgesics prior to surgery and for 72 
hours post-operatively.  
Tube Externalization 
After the recovery period, the mice were anesthetized with isoflurane (2%) 
to exteriorize the distal end of the tubing for cystometry. The stitches in the back of 
the neck were removed, the extra length of tubing was removed from the 
subcutaneous space, and the neck was resealed with GLUture. Tape was used to 
cover the externalized tubing to prevent any chewing damage.  
Bladder function evaluation with cystometry 
The mice were placed unrestrained in a cystometry recording cage with a 
wire floor. The tubing was connected to a pressure transducer port, which was 
connected to a syringe pump that infused saline at a constant rate (25 μl/min) to 
produce repetitive bladder contractions. Measuring began after a 15-minute 
anesthesia recovery period and acclimation time. A pan on a balance placed below 
the cage was used to catch and measure urine output. The minimum pressure, fill 
pressure, voiding threshold pressure, maximal voiding pressure, ICI, bladder 
capacity, and void volume was recorded by a small Animal Cystometry System (Med 
Associates, St. Albans, VT). Bladder capacity was measured as the infused volume 
between micturitions. To measure the effects of a PACAP blockade, the mice were 
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given a continuous 300 nM infusion of PACAP(6-38), a PAC1 receptor antagonist, for 
thirty minutes. This was done by first disconnecting the mouse’s tubing, removing 
remaining saline from the tubing, filling with PACAP antagonist solution, and then 
reconnecting the tubing and restarting the infusion pump. Following this period, the 
line was again flushed to remove remaining antagonist before a second round of 
recording with the saline infusion.   
Tissue Collection & Preparation 
The mice were euthanized via isoflurane (5%) and thoracotomy. The brain, 
spinal cord, DRG, and bladder were removed. Detrusor and urothelium layers were 
separated from each other. Tissues were placed in a 4% paraformaldehyde solution 
in a phosphate buffered saline (PBS) solution overnight, which was replaced by a 
30% sucrose solution in PBS for the following week. Detrusor and urothelium were 
cross-sectioned through the longer plane using surgical scissors. The other tissues 
were embedded in an OCT compound within a cryomold cassette for sectioning. The 
tissue was sectioned using a cryostat and mounted onto slides (DRG, 10μm) or free-
floated in wells (brain and spinal cord sections, 40μm).  
Immunohistochemistry 
Immunohistochemistry using anti-TRPV4-ATTO-550 (#ACC-034-AO, 
Alomone Labs, Jerusalem, Israel) and VR1 primary antibody (R-130, Santa Cruz, 
Santa Cruz, CA) was used to determine the expression of TRPV1 and TRPV4 
channels. Species-specific secondary antibodies tagged with fluorophores distinct 
from GFP were used to label both TRPV1 and TRPV4. Antibody specificity was 
previously demonstrated using DRG and spinal cord tissue harvested from TRPV1 
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and TRPV4 null mice.  In tissues from TRPV1 and TRPV4 null mice, no TRPV1- or 
TRPV4-immunoreactivity, respectively, was demonstrated.  Additionally, the 
transgenic mice (PACAP-GFP) are designed to exhibit green fluorescent protein 
(GFP) expression at sites with PACAP expression. Then the slides were viewed with 
a fluorescence microscope to determine the location and expression density of the 
TRPV channels of interest. Optical density and co-expression software with confocal 
microscopy were used to quantify expression, changes in expression and co-
expression of TRPV channels and PACAP. 
Statistical Analyses 
 All values represent means ± SE. Cystometry data were compared using 
paired t-tests and ANOVA, with each animal serving as its own control. 
Immunohistochemical data were compared with independent t-tests. Statistics were 
run using SPSS software obtained through The University of Vermont.  
Results 
Bladder Function 
 Generally, a healthy bladder results in relatively high bladder capacity with 
low pressure and therefore relatively long inter-micturition intervals. All bladder 
pressure values should be relatively low, with the peak micturition pressure having 
the highest value.  
Females. There was no significant difference between control and stressed 
functional values before PACAP(6-38) infusion. Both control and stressed female 
groups saw improvement on all functional measures after infusion. Control mice 
saw significant improvement post-infusion on ICI measures (t(5) = 3.461, p ≤ 0.05) 
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and bladder capacity (t(5) = 3.466, p ≤ 0.05) (Fig. 1 & 2). Threshold, minimum, fill, 
and maximum pressures all decreased post-infusion but not significantly (Fig. 3). 
The stressed cohort saw significant improvement post-infusion on ICI measures (p ≤ 
0.05) and bladder capacity (p ≤ 0.05) (Fig. 4 & 5). While all pressure measures did 
decrease post-infusion, no changes were significant (Fig. 6). 
Males.   There were no significant differences between control and stressed 
functional values before PACAP(6-38) infusion. Both control and stressed male 
groups saw improvement on all functional measures after infusion. Control mice 
had non-significant increases in ICI and bladder capacity (Fig. 7 & 8) and decreases 
in all pressure values (Fig. 9). Stressed mice had significant increases in ICI (t(6) = 
4.312, p ≤ 0.01) and bladder capacity (t(6) = 4.310, p ≤ 0.01) (Fig. 10 & 11). All four 
pressure values were decreased, with minimum pressure (t(6) = 3.065, p ≤ 0.05) 
and fill pressure (t(5) = 2.452, p ≤ 0.05) being significantly so (Fig. 12).  
Histology  
 In the DRG, there was increased expression of TRPV1-IR and PACAP-IR cells 
in the stressed mice (Fig. 12 & 13). These increases were significant at the L1 (p ≤ 
0.001), L2 (p ≤ 0.01), L6 (p ≤ 0.01), and S1 (p ≤ 0.001) levels. PACAP-IR was also 
increased under stress conditions at all levels of the DRG, with significant increases 
at L1 (p ≤ 0.001), L5 (p ≤ 0.05), and S1 (p ≤ 0.05). The number of cells expressing 
both TRPV1-IR and PACAP-IR was similar between stressed and control samples at 
all levels of the DRG. 
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Discussion 
Bladder Function 
 The repeated variate stress regime decreased ICI and bladder capacity while 
increasing bladder pressures in both male and female mice. This presentation is 
remarkably similar to that seen in animal models of IC/BPS. These results suggest 
that chronic levels of stress are capable of producing functional changes in the 
urinary system. Stress was the only experimental condition in this research, which 
suggests that these urinary changes may occur in the absence of other contributing 
factors, such as disease. When combined with another condition like IC/BPS or 
spinal cord injury, stress could then exacerbate current symptoms or add new 
complications.   
Intravescial PACAP(6-38) Infusion 
PACAP(6-38) was shown to aid urinary bladder function across all 
experimental groups. Improvement was seen most consistently in ICI and bladder 
capacity values, with female control, female stressed, and male stressed cohorts 
showing significant improvement. This provides supporting evidence to target 
PACAP for symptom relief.  
Female stressed and control mice showed better functional values after 
PACAP(6-38) infusion. Neither group showed significant changes from their pre-
infusion values. Because both stressed and controls saw similar levels of functional 
improvement, the effect of PACAP(6-38) infusion on bladder function may be 
universally beneficial.  This would also suggest, then, that the magnitude of effect of 
PACAP(6-38) on the urinary bladder is not improved in the presence of stress. 
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PACAP(6-38) could be working in a non-specific manner to generally improve the 
function of the bladder without addressing the specific mechanism(s) altered by 
stress. Brass and colleagues (2005) have found evidence for PACAP(6-38) in cystitis 
symptom alleviation. This provides support for a positive effect on inflammatory 
states, despite the method of impact.   
This equal improvement in both experimental groups was not the case in the 
male mice. While all functional values of stressed and control male mice improved 
with infusion, stressed mice showed more improvement than controls. This was 
seen in the significant decreases in minimum and fill pressures for stressed mice 
post-infusion. This would suggest that stress might increase the magnitude of effect 
for this therapy, whether it is caused by an increase in general health of the system 
or by improvement of a stress-specific mechanism.  
Additionally, both theories may be right and there may be sex differences in 
urinary innervation, control, and response to stress. Overall, these sex differences in 
response to therapy may also suggest that the PACAP(6-38) infusion is having sex-
dependent effects on bladder function. This could be the result of differing 
mechanisms of bladder innervation or varying levels of contribution the PACAP 
mechanisms may have on overall function.  
Mouse estrous cycles were not controlled for in this experiment, which could 
be a confounding variable in the female response to stress. Other experiments on 
bladder function have made efforts to control for estrous cycles (Wang et al., 2008). 
Shea and colleagues (2000) have suggested that sensory innervation to the bladder 
could be sensitive to hormonal status, especially mechanoreceptive input. Johnson 
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and Berkley (2002) found that threshold pressure of inflamed bladders, but not 
normal bladders, was influenced by estrous state. This could be a direct result of 
hormones or, more likely, the interaction between hormones and sensory 
neurotransmitters. This could contribute to the increased variability seen in female 
mice groups, and should be taken into consideration with housing style and timing 
of future experiments.  
Neither of the stressed groups was significantly worse in baseline functional 
values when compared to their control counterparts. This may raise questions to the 
validity of the repeated variate stress regime and if the stressed cohorts were 
actually stressed to a substantial degree to be considered a good model for chronic 
stress. However, functional values for stressed groups were on average worse than 
controls before administration of PACAP(6-38). All values trended in the expected 
direction under stress despite significance. These animals were also visibly stressed, 
as seen by anxiety-like behaviors including increased startle, frequent 
urination/defecation, and hair loss. These behaviors were not measured.  
Further measures like blood cortisol levels could be taken to determine 
stress level. Preliminary cortisol measurements done in new groups of male control 
(n=4) and stressed (n=5) and female control (n=5) and stressed mice (n=5) showed 
that stressed groups had higher average cortisol levels than control groups. Neither 
female (p = .102) nor male (p = .068) was significantly above the control condition. 
Being that this is preliminary testing, a larger sample size could lead to significance 
and a stronger argument for substantial stress under the repeated variate stress 
regime.  
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Histology 
 The stressed male mice saw significantly increased rates of both PACAP- and 
TRPV1-IR cells in the DRG. This would support the theory that PACAP is a sensory 
neurotransmitter that participates in the relay of sensory information, especially 
nociception. The increase in expression suggests that more noxious input is sent to 
CNS control centers, contributing to higher levels of reflexive urge to 
urinate/bladder contractions and perceived pain or discomfort. This, then, could 
account for accommodating changes in bladder function in an attempt to react to 
this abnormal sensory information. It could also explain the increased awareness of 
the urinary bladder state (notably pain), resulting in psychological symptom 
development. Therapies targeting PACAP, then, are targeting the afferent branch of 
this loop, reducing information transmission before it reaches the central relay 
centers.  
PACAP-IR cells in the bladder provide support for the presence of this 
powerful substrate in peripheral tissue, with physiological functions in the 
immediate area. PACAP may also have an immediate effect on release, as it has been 
shown before to act in a localized manner on smooth muscle inhibition and indirect 
excitation (Fox-Threlkeld et al., 1999). The location and function of the detrusor 
smooth muscle in bladder reflexology lends itself as a possible target for PACAP 
upregulation.  
Future Directions 
 This work should be continued in an effort to fully describe the effect of 
chronic stress on the body. Further research on both sexes with control for estrous 
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cycle will help to determine the real differences in control and organization of the 
urinary bladder innervation that may lead to varying presentations of stress and 
responses to therapeutics. It is unclear what factor of urinary control and output 
may be causing these apparent sex differences in this experiment.  
PACAP(6-38) infusion improved bladder function overall and therefore 
PACAP receptors may be a valid target for therapy for those with bladder 
dysfunction caused or exacerbated by stress. Because chronic stress presents with 
symptoms similar to other conditions, notably cystitis, PACAP(6-38) administration 
should be evaluated in other bladder dysfunction states.  
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Figure 1. Average inter-micturition 
interval for female control PACAP-GFP 
mice during voiding contractions.
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Figure 2. Average maximum infused 
volume (bladder capacity) into control 
female PACAP-GFP mice during voiding 
contractions.
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Figure 4. Average inter-micturition 
interval for female stressed PACAP-GFP 
mice during voiding contractions.
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Figure 5.  Average maximum infused 
volume (bladder capacity) into female 
stressed PACAP-GFP mice during 
voiding contractions.
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Figure 3. Urinary bladder pressures in control 
female PACAP-GFP mice throughout the 
micturition cycle. 
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Figure 6. Urinary bladder pressures in stressed 
female PACAP-GFP mice throughout the 
micturition cycle. 
Threshold Pressure
Minimum Pressure
Average (Fill)
Pressure
Maximum Pressure
 25 
 
 
0
50
100
150
200
250
PRE POST
A
v
e
ra
g
e
 M
a
x
im
u
m
 V
o
lu
m
e
 (
m
L
)
PACAP(6-38) Infusion
Figure 8. Average maximum infused 
volume (bladder capacity) for control 
male PACAP-GFP mice during voiding 
contractions.
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Figure 7. Average inter-micturition 
interval for control male PACAP-GFP 
mice during voiding contractions.
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Figure 11. Average maximum infused 
volume (bladder capacity) for stressed 
male PACAP-GFP mice during voiding 
contractions.
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Figure 10. Average inter-micturition 
interval for stressed male PACAP-GFP 
mice during voiding contractions.
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Figure 9. Urinary bladder pressures in control male 
PACAP-GFP mice throughout the micturition cycle. 
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Figure 12. TRPV- and PACAP-IR in DRG 
sections at the L1 level of a stressed 
mouse.  
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Figure 13. TRPV- and PACAP-IR in DRG sections at 
the L6 level of stressed mouse.  
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